PIRADS V2.1 - What a Urologist Needs to Know with Dr. Sadhna Verma
Sadhna Verma, MD, MBA, FSAR, is a Professor of Radiology, Radiation Oncology and Urology at the University of Cincinnati Medical Center, Cincinnati, Ohio. She begins this 20-minute presentation by emphasizing the exponential growth of prostate MRI usage and its critical role in prostate cancer detection. The discussion transitions to PI-RADS scoring and an analysis of PI-RADS version 2.1.
▶︎
Introduction to Prostate MRI and PI-RADS: Approach and Principles
▶︎
Webinar Micro Ultrasound Masterclass - A Clinical Overview
▶︎
Adaptive Radiotherapy with Dr. Richard G. Stock, MD
▶︎
Coronary S1 - Complications Part 1: Acute Vessel Closure - CVI 2024
▶︎
Trump wants to be ‘THE LAST PRESIDENT’ - Maggie Haberman
▶︎
5.15.2020 Urology COViD Didactics - Prostate MRI for Urologists
▶︎
Living With A Pacemaker (common questions answered) - in Plain English!
▶︎
Advanced Prostate Cancer Treatment Options: New Therapies, Genetic Testing, and Emerging Research
▶︎
Management of Men With PI-RADS 4-5 Lesions and Negative Biopsy
▶︎
Who should get a prostate biopsy? | Peter Attia & Ted Schaeffer
▶︎
Dr. Amar Kishan talks to the Prostate Cancer Information Group about high-dose SBRT and ADT.
▶︎
Is PSA Density Still Relevant? #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
▶︎
2026 - MS - The Clue Was the Blood Pressure: Atypical Erdheim-Chester Disease - Jithma Abeykoon
▶︎
DSC-MRI: From Concepts to Clinical Practice | GliMR Educational Webinar
▶︎
New MRI methods and preclinical models to assess the brain tumor microenvironment | Webinar
▶︎
Prostate MRI for the Urologist
▶︎
What is an MRI PI-RADS Score? | #MarkScholzMD & Alex Scholz | #PCRI #ProstateCancer
▶︎
CMR Masterclass Course V: CMR in Inflammatory and Infiltrative Myocardial Diseases.
▶︎
Genomic Testing for Prostate Cancer: Current Value in the Era of MRI and Clinical Prognostic Factors
▶︎